rawfin.tv
RTX Outperforms Honeywell Since Dow Jones Replacement, Raising Questions
MarketsstocksAI Generated

RTX Outperforms Honeywell Since Dow Jones Replacement, Raising Questions

RTX has significantly outperformed Honeywell International since its removal from the Dow Jones Industrial Average, with a 231% gain. This performance disparity raises questions about the index's decision and the relative investment merits of both companies.

By rawfin.tv Markets Desk||5 min read|AI-assisted Β· Methodology

Key Takeaways

  • Raytheon Technologies ($RTX) has delivered a 231% total return since its August 31, 2020, inclusion in the Dow Jones Industrial Average ($DJIA).
  • In contrast, Honeywell International ($HON), removed from the Dow on the same date, recorded a more modest 37% gain over the identical period.
  • This 194 percentage point performance disparity has prompted scrutiny of the Dow's index committee's rationale and its impact on investor perception.
  • The divergence underscores varying investor expectations for post-pandemic aerospace recovery versus diversified industrial growth strategies.
  • Investors are now re-evaluating the long-term growth catalysts and inherent risk profiles of both industrial sector giants.

RTX's Post-Dow Inclusion Surge Prompts Index Scrutiny

Raytheon Technologies ($RTX) has delivered a staggering 231% total return since its inclusion in the Dow Jones Industrial Average ($DJIA) on August 31, 2020, significantly outpacing its former peer, Honeywell International ($HON), which was simultaneously removed from the index. This substantial outperformance, marking a 194 percentage point difference over the past three and a half years, has ignited debate among market participants regarding the efficacy of the Dow's index committee decisions and the underlying investment theses for both industrial conglomerates.

The move saw $RTX shares trade at approximately $62.50 at the time of its Dow entry, climbing steadily to over $210 by early 2024, reflecting robust investor confidence in its aerospace and defense segments. In contrast, $HON, trading around $175 in August 2020, has advanced to roughly $240, experiencing a more subdued growth trajectory despite its diversified portfolio. This stark divergence in market capitalization growth, with $RTX adding over $200 billion to its valuation while $HON added approximately $40 billion, has led to a re-evaluation of relative valuations and sector exposures within the industrial landscape.

Market Impact

The dramatic divergence in stock performance between $RTX and $HON has sent ripples across the industrial sector, shifting investor capital and sentiment. At its Dow inclusion, $RTX commanded a market capitalization of approximately $95 billion, which has since swelled to over $300 billion as of early 2024. This growth was fueled by a consistent upward trend, with the stock experiencing multiple significant rallies, including a 30% surge in the six months following its Dow entry.

Conversely, $HON's market capitalization grew from roughly $120 billion to $160 billion over the same period, a respectable but comparatively muted increase. The period since late 2020 coincided with a robust global recovery in commercial aerospace, a key driver for $RTX's Pratt & Whitney and Collins Aerospace units, which saw order backlogs expand rapidly. This momentum was further amplified by sustained global defense spending, directly benefiting $RTX's Raytheon Missiles & Defense and Raytheon Intelligence & Space segments.

For $HON, its more diversified portfolio spanning industrial automation, building technologies, and performance materials, while offering stability, may have provided less direct leverage to the specific, high-growth recovery themes that propelled $RTX. While $HON experienced its own periods of strength, such as a 15% gain in Q4 2021 driven by strong industrial demand, its overall trajectory lacked the explosive growth seen in its aerospace-heavy counterpart. The performance gap has also influenced broader industrial sector exchange-traded funds ($XLI), where $RTX holds a significant weighting, contributing disproportionately to the sector's overall gains.

What Analysts Are Saying

Institutional analysts have offered varied perspectives on the performance disparity, largely attributing $RTX's outperformance to its concentrated exposure to the aerospace and defense sectors. "JP Morgan analysts highlighted $RTX's strong leverage to the global commercial aerospace recovery, particularly in post-pandemic travel demand," noting robust order backlogs for Pratt & Whitney engines and Collins Aerospace systems as a key driver of earnings growth. Morgan Stanley echoed this sentiment, pointing to "sustained global defense spending as a foundational driver for $RTX's Raytheon Missiles & Defense and Raytheon Intelligence & Space segments, projecting stable, high-margin revenue streams through the end of the decade."

The narrative for Honeywell, while positive on its intrinsic value, often centered on its diversification providing stability over explosive growth during this specific market cycle. "Goldman Sachs noted that while $HON's broad diversification provides resilience across economic cycles, it might have limited its upside exposure to specific high-growth sectors that propelled $RTX," resulting in a more moderate growth profile. Citi analysts acknowledged $HON's strong fundamentals and consistent free cash flow generation but cited "ongoing supply chain disruptions affecting its industrial automation and safety segments, potentially capping near-term earnings growth until mid-2024."

Some strategists have also weighed in on the Dow's index committee decision itself. "Strategists at Bank of America suggest the Dow committee's decision might have been based on a forward-looking view that $RTX offered greater growth potential post-pandemic, especially given its repositioning following the United Technologies merger," even if the initial optics of removing a well-established industrial giant like $HON were questioned. This perspective implies a long-term strategic bet on global aerospace and defense that has, so far, paid off for the index.

What to Watch

Investors monitoring $RTX should closely track several key catalysts. Commercial aerospace demand remains paramount, with updates on Boeing ($BA) and Airbus ($AIR.PA) production rates providing direct insights into engine and component order volumes. Global defense budget trends, particularly from the U.S. Department of Defense and key international allies, will dictate the pace of new contracts and program funding. Geopolitical risks, while a potential driver for defense spending, also present execution risks. Additionally, the ongoing Pratt & Whitney GTF engine issues, including inspection requirements and associated costs, will be critical to monitor. For $RTX, key resistance levels are observed at $215 and $220, with strong support around $195.

For $HON, the industrial automation cycle and global capital expenditure trends in manufacturing are crucial, as they directly impact its Process Solutions segment. The recovery of commercial real estate and infrastructure spending will influence its Building Technologies unit. Progress in supply chain normalization, easing input costs, and improving delivery times could significantly boost margins across its segments. Honeywell's strategic mergers and acquisitions (M&A) strategy, including potential divestitures or acquisitions, could also serve as a catalyst for growth. Key resistance levels for $HON are at $245 and $255, with support established at $230.

Beyond individual company specifics, the broader industrial sector earnings season, with reports typically due in late January and April, will provide an overarching view of demand. The prevailing interest rate environment will also influence capital expenditures, impacting both companies. Finally, global economic growth forecasts, particularly in key manufacturing regions and emerging markets, will shape the macro backdrop for these industrial giants.

RTXHoneywellDow JonesStock PerformanceDefense StocksIndustrial Sector

Related Articles